Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells. | Int J Mol Sci | 2021 | 35008560 | PubTator, text mining | PubMed |
| The Micro-Immunotherapy Medicine 2LEID Exhibits an Immunostimulant Effect by Boosting Both Innate and Adaptive Immune Responses. | Int J Mol Sci | 2021 | 35008536 | PubTator, text mining | PubMed |
| Tumor-Associated Regulatory T Cell Expression of LAIR2 Is Prognostic in Lung Adenocarcinoma. | Cancers (Basel) | 2021 | 35008369 | PubTator, text mining | PubMed |
| Controlled Modular Multivalent Presentation of the CD40 Ligand on P22 Virus-like Particles Leads to Tunable Amplification of CD40 Signaling. | ACS Appl Bio Mater | 2021 | 35005938 | PubTator, text mining | PubMed |
| Boosting Vaccine-Elicited Respiratory Mucosal and Systemic COVID-19 Immunity in Mice With the Oral Lactobacillus plantarum. | Front Nutr | 2021 | 35004816 | PubTator, text mining | PubMed |
| Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection. | Front Immunol | 2021 | 35003077 | PubTator, text mining | PubMed |
| Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma. | Front Immunol | 2021 | 35003069 | PubTator, text mining | PubMed |
| CAR-NK Cells: From Natural Basis to Design for Kill. | Front Immunol | 2021 | 34970253 | PubTator, text mining | PubMed |
| Identification of Subtypes and a Prognostic Gene Signature in Colon Cancer Using Cell Differentiation Trajectories. | Front Cell Dev Biol | 2021 | 34966734 | PubTator, text mining | PubMed |
| Predictors of colorectal cancer survival using cox regression and random survival forests models based on gene expression data. | PLoS One | 2021 | 34965262 | PubTator, text mining | PubMed |
| A Bioinformatics Approach to Identifying Potential Biomarkers for Cryptosporidium parvum: A Coccidian Parasite Associated with Fetal Diarrhea. | Vaccines (Basel) | 2021 | 34960172 | PubTator, text mining | PubMed |
| Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy. | Vaccines (Basel) | 2021 | 34960140 | PubTator, text mining | PubMed |
| A Retrospective Analysis: Autologous Peripheral Blood Hematopoietic Stem Cell Transplant Combined With Adoptive T-Cell Therapy for the Treatment of High-Grade B-Cell Lymphoma in Ten Dogs. | Front Vet Sci | 2021 | 34950726 | PubTator, text mining | PubMed |
| Protumorigenic Role of Elevated Levels of DNA Polymerase Epsilon Predicts an Immune-Suppressive Microenvironment in Clear Cell Renal Cell Carcinoma. | Front Genet | 2021 | 34950188 | PubTator, text mining | PubMed |
| Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer. | Int J Mol Sci | 2021 | 34948446 | PubTator, text mining | PubMed |
Increased Susceptibility of the CD57- NK Cells Expressing KIR2DL2/3 and NKG2C to iCasp9 Gene Retroviral Transduction and the Relationships with Proliferative Potential, Activation Degree, and Death Induction Response. | Int J Mol Sci | 2021 | 34948123 | PubTator, text mining | PubMed |
| Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions. | Int J Mol Sci | 2021 | 34948104 | PubTator, text mining | PubMed |
| Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia. | Cancers (Basel) | 2021 | 34944865 | PubTator, text mining | PubMed |
| Transcriptomic profiling and pathway analysis of cultured human lung microvascular endothelial cells following ionizing radiation exposure. | Sci Rep | 2021 | 34930946 | PubTator, text mining | PubMed |
| Identification and Validation of the lncRNA BACE1-AS as Immune-Related Influencing Factor in Tumorigenesis following Pan-Carcinoma Analysis. | J Immunol Res | 2021 | 34926701 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=58